Cargando…

Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation

OBJECTIVES: Other than age, diabetes is the largest contributor to overall healthcare costs and reduced life expectancy in Europe. This paper aims to more exactly quantify the net impact of diabetes on different aspects of healthcare provision in hospitals in England, building on previous work that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stedman, Mike, Lunt, Mark, Davies, Mark, Livingston, Mark, Duff, Christopher, Fryer, Anthony, Anderson, Simon George, Gadsby, Roger, Gibson, Martin, Rayman, Gerry, Heald, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223153/ https://www.ncbi.nlm.nih.gov/pubmed/32376746 http://dx.doi.org/10.1136/bmjopen-2019-033231

Ejemplares similares

The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
por: Stedman, Mike, et al.
Publicado: (2021)

Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes
por: Heald, Adrian, et al.
Publicado: (2019)

People with Type 2 Diabetes Mellitus (T2DM) Self-Reported Views on Their Own Condition Management Reveal a High Level of Insight into the Challenges Faced
por: Stedman, Mike, et al.
Publicado: (2021)

Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response
por: Heald, Adrian H., et al.
Publicado: (2021)

Real‐world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes
por: Heald, Adrian H., et al.
Publicado: (2018)

National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM)
por: Al-Rubeaan, Khalid
Publicado: (2015)

New-Onset Type 1 Diabetes Mellitus (T1DM) in a Pediatric Patient with Beckwith-Wiedemann Syndrome
por: Ehsan, Lubaina, et al.
Publicado: (2023)

The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)
por: Kelly, Katherine, et al.
Publicado: (2016)

Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation With Microvascular Complications
por: Hulkoti, Vidyashree, et al.
Publicado: (2022)

Detecting Frailty in Elderly Type 2 Diabetes Mellitus (T2DM) Patients in the Southeast of Brazil
por: Ramos-Dias, João Carlos, et al.
Publicado: (2021)

OR29-4 Prevention of Type 2 Diabetes by Testosterone in the T4DM Trial: Analysis of Effect Mediation
por: Wittert, Gary
Publicado: (2022)

Clinical and biochemical characteristics of familial type 1 diabetes mellitus (FT1DM) compared to non-familial type 1 DM (NFT1DM)
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period
por: Heald, Adrian, et al.
Publicado: (2022)

Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar
por: Alyafei, Fawzia, et al.
Publicado: (2018)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

Age of people with type 2 diabetes and the risk of dying following SARS‐CoV‐2 infection
por: Tian, Zixing, et al.
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis Post Bariatric Surgery in Type II DM in the Setting of SGLT2-Inhibitor Use
por: Alfares, Khalid, et al.
Publicado: (2021)

Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity
por: Khalili, Farnaz, et al.
Publicado: (2021)

Gut microbiota influence in type 2 diabetes mellitus (T2DM)
por: Cunningham, A. L., et al.
Publicado: (2021)

Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
por: Luo, Jian-Quan, et al.
Publicado: (2023)

Anaemia among primary care patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD): a multicentred cross-sectional study
por: Idris, Iliza, et al.
Publicado: (2018)

Challenges in the Management of Type 1 Diabetes Mellitus (T1DM) in a Pediatric Patient Due to Social Determinants of Health: A Case Report
por: Gianvecchio, Crystal, et al.
Publicado: (2023)

Type 2 diabetes and mortality in females versus males in England: the Salford diabetes cohort
por: Heald, Adrian H., et al.
Publicado: (2023)

Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
por: Wu, Xu, et al.
Publicado: (2021)

Developments in the Management of Type 1 and Type 2 Diabetes
por: Mathieu, Chantal
Publicado: (2018)

Financial Incentives and Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM): a trial protocol
por: Egede, Leonard E, et al.
Publicado: (2020)

FRI651 Usage Of Modern Sulphonylureas And Metformin Fixed Dose Combination (fdc) In Type 2 Diabetes Mellitus (t2dm) Patients With Established Complications
por: M, Aushili, et al.
Publicado: (2023)

ODP183 Diabetic Ketoacidosis Precipitated by Ketogenic Diet and SGLT-2 Inhibitor Use in an Individual with T2DM
por: Mason, Timothy, et al.
Publicado: (2022)

Mild Cognitive Impairment Screening in Older Adults With Type 2 DM
por: Pirela, Daniela Victoria, et al.
Publicado: (2021)

Polyuria with the Concurrent manifestation of Central Diabetes Insipidus (CDI) & Type 2 Diabetes Mellitus (DM)
por: Shin, Hyun-Jong, et al.
Publicado: (2012)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)

Type 2 Diabetes Mellitus (T2DM) and Carbohydrate Metabolism in Relation to T2DM from Endocrinology, Neurophysiology, Molecular Biology, and Biochemistry Perspectives
por: Mills, Hilla, et al.
Publicado: (2022)

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?
por: Kloc, Małgorzata, et al.
Publicado: (2020)

Excellent Outcome of Protocol-Based Treatment of Motivated Type 2 Diabetes Mellitus (T2DM) Patients: A Real World Follow-Up for 11 Years
por: Chatterjee, Sudip, et al.
Publicado: (2020)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea
por: Cho, Minho, et al.
Publicado: (2008)

Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
por: Sabari, S. Sri, et al.
Publicado: (2023)

Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
por: Sayyed Kassem, Laure, et al.
Publicado: (2023)

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies
por: Ray, Kausik K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mn8spujfd6prfkunndsdvvu18p